Metformin lowers blood sugar primarily by reducing the amount of glucose your liver produces. It’s the most widely prescribed diabetes medication in the world, typically lowering HbA1c (a measure of average blood sugar over three months) by about 1.12 percentage points when used alone. But metformin does more than manage blood sugar, and its effects reach well beyond the liver.
How Metformin Lowers Blood Sugar
Your liver constantly releases glucose into your bloodstream, even when you haven’t eaten. In people with type 2 diabetes, this process runs too high. Metformin dials it back by about 15 to 20%, which is enough to make a meaningful difference in daily blood sugar levels.
The way it achieves this is surprisingly specific. Metformin blocks a particular enzyme involved in converting certain raw materials (especially glycerol and lactate) into new glucose molecules. This shifts the chemical balance inside liver cells in a way that slows glucose production at the source. Older theories suggested metformin worked by disrupting the cell’s energy-producing machinery, but that effect only appears at concentrations far higher than what the drug actually reaches in your body.
Metformin also works in the gut. It changes the bacterial composition of the upper small intestine, increasing beneficial bacteria like Lactobacillus, and improves the way your intestinal lining senses and responds to glucose. This gut-level effect appears to be a genuinely separate mechanism from what happens in the liver, which helps explain why metformin’s benefits are broader than you’d expect from a single pathway.
Weight Loss Effects
Metformin causes modest weight loss in most people who take it, though the amount varies. In clinical trials of people with type 2 diabetes, weight loss ranged from about 2.7 kg (6 lbs) over four years to as much as 8 kg (17.6 lbs) over 24 weeks, with the higher end linked to higher doses. One study found a dose-dependent effect on appetite, meaning people on more metformin simply ate less.
For people without diabetes, the numbers are smaller. Studies have found losses of roughly 2 to 2.8 kg (4.4 to 6.2 lbs) over periods ranging from one month to a year. In the large Diabetes Prevention Program trial, participants at high risk for diabetes lost an average of 2.1 kg, but those who took the medication consistently saw about a 3.5% reduction in body weight over two years. People who were less consistent with the medication stayed roughly weight-neutral.
This makes metformin a mild weight loss aid at best. It won’t produce the dramatic results of newer injectable medications, but it consistently nudges weight downward rather than upward, which sets it apart from many other diabetes drugs that cause weight gain.
Metformin for PCOS
Polycystic ovary syndrome (PCOS) is one of the most common off-label uses for metformin. Many women with PCOS have insulin resistance, and by improving how the body handles insulin, metformin can help restore ovulation and improve fertility outcomes.
A large Cochrane review found that metformin roughly doubled the odds of ovulation compared to placebo. Ovulation rates went from about 24% with placebo to somewhere between 37% and 54% with metformin. Clinical pregnancy rates were also higher, and live birth rates improved modestly, from 19% with placebo to between 19% and 37% with metformin.
Body weight matters here. In non-obese women with PCOS, metformin performed comparably to or even slightly better than clomiphene (the standard fertility drug) for pregnancy rates. In obese women, metformin was significantly less effective than clomiphene for ovulation, pregnancy, and live births. Adding metformin to clomiphene may boost ovulation rates from about 50% to between 58% and 68%, though the improvement in live births is less certain.
Common Side Effects
Gut problems are by far the most common complaint. In a large meta-analysis, about 13% of users experienced diarrhea, 9% had bloating, roughly 6.5% reported nausea or abdominal pain, and about 4% had vomiting. Constipation was less common at around 2%.
These side effects are usually worst in the first few weeks and tend to improve over time. Three strategies help reduce them: starting at a low dose and increasing gradually, taking the medication with food, and switching to the extended-release formulation if the immediate-release version causes trouble. UK guidelines specifically recommend the extended-release version for people who can’t tolerate the standard form. If symptoms flare up, lowering the dose temporarily and trying again often works.
The most feared side effect, lactic acidosis (a dangerous buildup of acid in the blood), is extremely rare. Estimates put the incidence at roughly 3 to 10 cases per 100,000 patients per year. This risk is highest in people with severe kidney disease, which is why kidney function is checked before starting the medication and monitored periodically.
Vitamin B12 Depletion
Metformin interferes with vitamin B12 absorption, and this effect builds over time. In the Diabetes Prevention Program study, about 5% of metformin users had low B12 after 5 years, rising to over 9% after 13 years. When borderline-low levels were included, about 20% of long-term users were affected.
B12 deficiency can cause numbness and tingling in the hands and feet, fatigue, and memory problems. These symptoms overlap with diabetic nerve damage, so they can easily be missed. Despite decades of evidence linking metformin to low B12, routine screening still hasn’t been added to most clinical practice guidelines. If you’ve been on metformin for several years and haven’t had your B12 checked, it’s worth asking about. A simple blood test can catch it, and supplementation is straightforward.
Dosing and How It’s Taken
Most people start on 500 mg once or twice daily for the immediate-release form, or 500 to 1,000 mg once daily for extended-release. The dose is increased gradually over several weeks to reduce gut side effects. The maximum daily dose for immediate-release is 2,550 mg, while extended-release tops out at 2,000 mg.
Taking metformin with meals reduces stomach upset and improves absorption. The extended-release version is typically taken once daily with dinner, while the immediate-release form is usually split across two or three meals.
Metformin and Aging
You may have seen headlines about metformin as an anti-aging drug. Early observational studies were striking: people with type 2 diabetes taking metformin appeared to have better survival rates than people in the general population without diabetes, along with lower rates of cancer and heart disease compared to those on other diabetes medications.
The reality is more complicated. When researchers looked more carefully, the evidence supporting anti-aging benefits in people without diabetes turned out to be weaker than initially thought. Clinical trials in non-diabetic populations have generally not shown the anticipated benefits. A large human trial designed to test metformin specifically as an aging intervention has been planned, but for now, the case for taking metformin purely to slow aging remains uncertain.